Dr. Gunuganti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
18707 Hardy Oak Blvd
Suite 320
San Antonio, TX 78258Phone+1 210-545-6972Fax+1 210-545-1016
Education & Training
- University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 2002 - 2004
- Marshfield ClinicResidency, Internal Medicine, 1999 - 2002
- Temple University HospitalInternship, Transitional Year, 1998 - 1999
- Osmania Medical College NTR UHSClass of 1995
- Deccan College of Medical Sciences NTRClass of 1995
Certifications & Licensure
- TX State Medical License 2005 - 2025
- WI State Medical License 2000 - 2011
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 106 citationsContinuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153.David M. Waterhouse, Edward B. Garon, Jason C. Chandler, Michael McCleod, Maen A. Hussein
Journal of Clinical Oncology. 2020-09-10 - 45 citationsSafety and Efficacy of Nivolumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study.Nicholas J Vogelzang, Mark R Olsen, Joshua J McFarlane, Edward Arrowsmith, Todd M Bauer
Clinical Genitourinary Cancer. 2020-12-01 - 17 citationsSafety and Efficacy of Nivolumab in Patients With Advanced Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study.Joshua J McFarlane, Mark D Kochenderfer, Mark R Olsen, Todd M Bauer, Ana Molina
Clinical Genitourinary Cancer. 2020-12-01
Other Languages
- Spanish, Hindi, Telugu, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: